Establishment Labs Inc. (ESTA)
| Bid | 29.75 |
| Market Cap | 907.2M |
| Revenue (ttm) | 166.03M |
| Net Income (ttm) | -84.6M |
| EPS (ttm) | -3 |
| PE Ratio (ttm) | -10.48 |
| Forward PE | -30.53 |
| Analyst | Buy |
| Ask | 32.23 |
| Volume | 551,005 |
| Avg. Volume (20D) | 602,087 |
| Open | 30.71 |
| Previous Close | 30.18 |
| Day's Range | 30.09 - 31.91 |
| 52-Week Range | 26.56 - 60.12 |
| Beta | 0.78 |
About ESTA
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander, as well as dis...
Analyst Forecast
According to 6 analyst ratings, the average rating for ESTA stock is "Buy." The 12-month stock price forecast is $52, which is an increase of 65.34% from the latest price.
Stock ForecastsNext Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago · seekingalpha.com
Establishment Labs Holdings Inc. (ESTA) Q4 2024 Earnings Call TranscriptEstablishment Labs Holdings Inc. (NASDAQ:ESTA ) Q4 2024 Earnings Conference Call February 26, 2025 4:30 PM ET Company Participants Raj Denhoy - CFO Juan Chacón-Quirós - CEO Peter Caldini - President C...
2 months ago · businesswire.com
Establishment Labs to Announce Fourth Quarter 2024 Financial Results on February 26NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...